ATE4956T1 - Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. - Google Patents

Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Info

Publication number
ATE4956T1
ATE4956T1 AT80303912T AT80303912T ATE4956T1 AT E4956 T1 ATE4956 T1 AT E4956T1 AT 80303912 T AT80303912 T AT 80303912T AT 80303912 T AT80303912 T AT 80303912T AT E4956 T1 ATE4956 T1 AT E4956T1
Authority
AT
Austria
Prior art keywords
preparation
nitroglycerine
medications
possibly
manufacture
Prior art date
Application number
AT80303912T
Other languages
English (en)
Inventor
Stewart Thomas Leslie
Alan Rhodes
Original Assignee
Mundipharma A.G.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma A.G. filed Critical Mundipharma A.G.
Application granted granted Critical
Publication of ATE4956T1 publication Critical patent/ATE4956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT80303912T 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. ATE4956T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7938380 1979-11-06
EP80303912A EP0028526B1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes Präparat und möglicherweise andere Medikamente und deren Herstellung

Publications (1)

Publication Number Publication Date
ATE4956T1 true ATE4956T1 (de) 1983-10-15

Family

ID=10508999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80303912T ATE4956T1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Country Status (6)

Country Link
US (2) US4322433A (de)
EP (1) EP0028526B1 (de)
AT (1) ATE4956T1 (de)
CA (1) CA1163561A (de)
DE (1) DE3065315D1 (de)
GB (1) GB2062465B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US4879308A (en) * 1987-08-11 1989-11-07 Lyphomed, Inc. Aqueous nitroglycerin injection and manufacturing process
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
US5268046A (en) * 1992-08-14 1993-12-07 Hercules Incorporated Surfactant stabilized nitroglycerin emulsion
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
EP0706394B1 (de) * 1994-03-02 2003-05-21 Professional Pharmaceutical, Inc. Verwendung einer Zusammensetzung enthaltend Histaminphosphat zur Herstellung eines Medikaments zur topischen Behandlung von epithelialen Entzündungen oder Läsionen
DK1051972T3 (da) * 1994-05-27 2008-01-28 Strakan Int Ltd Nitrogenoxiddonorsammensætning og fremgangsmåde til behandling af anale lidelser
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
SE520811C2 (sv) * 1997-01-17 2003-08-26 Ponsus Ab Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
CA2294480C (en) 1997-06-23 2008-05-20 Queen's University At Kingston Microdose therapy of female sexual dysfunction by no, co, and their donors
DE19819012A1 (de) * 1998-04-29 1999-11-25 Dynamit Nobel Ag Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
IL157734A0 (en) 2001-03-06 2004-03-28 Cellegy Pharma Inc Pharmaceutical compositions for the treatment of urogenital disorders
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
JP2005511529A (ja) * 2001-10-12 2005-04-28 エーキュー・プラス・ピーエルシー 金属イオンキレート剤を含有する抗生物質組成物
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
DE60316810T2 (de) 2002-08-02 2008-07-17 Ab Science 2-(3-aminoaryl)amino-4-aryl-thiazole und ihre verwendung als c-kit inhibitoren
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
PL1684750T3 (pl) * 2003-10-23 2010-10-29 Ab Science 2-Aminoarylooksazole jako inhibitory kinazy tyrozynowej
EP2361624A1 (de) * 2005-04-04 2011-08-31 AB Science Oxazolderivate und Ihre Anwendung als Tyrosinkinase Inhibitoren
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
EP2120945A1 (de) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamin-kombination
EP2363116A1 (de) 2008-06-25 2011-09-07 US Worldmeds LLC Lofexidin enthaltende Formulierungen mit verzögerter Freisetzung zur oralen Verabreichung
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
TWI523852B (zh) 2010-01-12 2016-03-01 Ａｂ科學公司 經取代之唑衍生物、含彼之組合物及其用途
TW201202232A (en) 2010-01-28 2012-01-16 Ab Science Treatment of GIST with masitinib
AU2012288900B2 (en) 2011-07-27 2016-10-06 Ab Science Selective protein kinase inhibitors
CA2943316A1 (en) 2014-03-24 2015-10-01 Ab Science Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors
ES2796276T3 (es) 2015-02-05 2020-11-26 Ab Science Compuestos con actividad antitumoral
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
WO2019114705A1 (zh) 2017-12-13 2019-06-20 上海小午医药科技有限公司 一种用于预防或治疗与egfr被抑制相关疾病的方法
CN111989095A (zh) 2018-04-16 2020-11-24 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法
US12070440B2 (en) 2022-06-27 2024-08-27 Permeatus, Inc. Topical formulations of nitroglycerin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395215A (en) * 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3609102A (en) * 1969-10-02 1971-09-28 Paris Cosmetics Inc Multicolored transparent polymer gel emollient bases, with oil-miscible dyes, for oil-soluble cosmetics, perfume and pharmaceuticals
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets
US4197318A (en) * 1974-07-08 1980-04-08 Johnson & Johnson Potentiated antimicrobial medicaments
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法

Also Published As

Publication number Publication date
GB2062465A (en) 1981-05-28
DE3065315D1 (en) 1983-11-17
EP0028526B1 (de) 1983-10-12
US4322433A (en) 1982-03-30
GB2062465B (en) 1984-01-25
EP0028526A2 (de) 1981-05-13
US4654209A (en) 1987-03-31
EP0028526A3 (en) 1981-11-25
CA1163561A (en) 1984-03-13

Similar Documents

Publication Publication Date Title
DE3065315D1 (en) A preparation containing nitroglycerine and optionally other medicaments and preparation thereof
KR880009639A (ko) 서방성 매트릭스 제형
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
ES8800037A1 (es) Procedimiento para solubilizar drogas en propulsores de aerosol a base de clorofluorcarburos
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
ATE17725T1 (de) Gegen entzuendung wirksame 5-substituierte 2,3diaryl-thiophene, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ES8201419A1 (es) Un metodo para preparar una solucion acuosa de nitrogliceri-na
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
IE791172L (en) Pharmaceutical compositions containing urea
DE69119810D1 (de) Pyrogensorbentmittel
ES2027773T3 (es) Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
ES8403463A1 (es) "un procedimiento para la preparacion de un compuesto de imidazol".
GB999739A (en) Analgesic compositions
BE881834A (fr) Medicaments et preparations pharmaceutiques a activite cytostatique
JPS577410A (en) Plaster
ES456094A1 (es) Un procedimiento para la preparacion de 2-acetoxi-benzoato de 2-(carbamoil) fenilo.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee